山药多糖对大鼠脑缺血再灌注损伤的药效及机制研究
该研究探讨山药多糖(RDPS)对大鼠脑缺血再灌注(IR)损伤的药效及可能机制。采用大脑中动脉闭塞(MCAO)模型和体外氧糖剥夺/复氧(OGD/R)模型,发现RDPS可减小脑梗死体积、降低MDA、升高GSH和SOD、降低IL-6、IL-1β和TNF-α,并可能通过调控CaMMKβ影响Nrf2/HO-1通路。
要点
- RDPS高、低剂量均可显著减小大鼠脑梗死体积。
- RDPS降低脑组织MDA,升高GSH和SOD活性。
- RDPS降低脑组织IL-6、IL-1β和TNF-α水平。
核心结论
- RDPS对大鼠脑缺血再灌注损伤具有药效作用,可减小脑梗死面积、上调抗氧化激酶活性、下调炎症因子。
- RDPS可能通过调控CaMMKβ表达影响Nrf2/HO-1信号通路激活。
- RDPS可能成为脑缺血再灌注损伤治疗的新策略,机制与改善抗氧化酶活性和抑制炎症反应有关。
研究设计与样本
- 体内实验采用大鼠大脑中动脉闭塞(MCAO)模型,测量脑梗死体积、氧化指标、炎症因子及脑组织CaMMKβ表达。
- 体外实验采用氧糖剥夺/复氧(OGD/R)模型,构建CaMMKβ干扰序列,检测BV2细胞中CaMMKβ表达及RDPS对Nrf2/HO-1信号通路的影响。
主要发现
- 与模型组相比,RDPS高剂量和低剂量组均可显著减小脑梗死体积。
- 两个RDPS剂量组脑组织MDA含量降低,GSH和SOD活性升高。
- RDPS治疗后脑组织IL-6、IL-1β和TNF-α水平低于模型组。
- 模型组大鼠脑组织CaMMKβ表达降低,而RDPS组CaMMKβ表达升高。
- 体外实验中,RDPS可调节OGD/R诱导的BV2细胞凋亡,并提高OGD/R诱导的CaMMKβ、Nrf2和HO-1水平;抑制CaMMKβ蛋白后上述治疗作用消失。
临床怎么用
- 原文为动物与细胞实验,尚未提供临床用药剂量或适应症推荐,临床不宜直接套用。
- 提示RDPS的神经保护作用可能与抗氧化和抗炎机制相关,可供后续转化研究参考。
局限性
- 研究仅在大鼠MCAO模型和BV2细胞OGD/R模型中开展,缺乏人体临床数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Rhizoma Dioscoreae (RD) is the rhizome of Dioscorea opposita Thunb., a traditional Chinese medicine, which can treat hypertension, diabetes, cerebral vasospasm headache and Alzheimer's disease. Meanwhile, RD is the main component of Liuwei Dihuang pill, a Chinese patent medicine. Rhizoma Dioscoreae polysaccharides (RDPS) are the primary active ingredient of RD. Modern medical research confirmed RDPS has multiple pharmacological effects, including neuroprotection, immunoregulation, antioxidant effect in many organs. The primary ischemia/hypoxia injury and secondary reperfusion injury are mainly caused by oxidative stress, which caused by hypoxia, such as free radical generation, energy metabolism disorder, intracellular calcium overload, excitatory amino acid release and inflammatory reaction. AIM OF THE STUDY: We have investigated the pharmacodynamic effect of RDPS on cerebral ischemia-reperfusion (IR) injury in rats and the possible mechanism in vitro. MATERIALS AND METHODS: The pharmacodynamic effect of RDPS on IR injury in rats was studied by the construction of the occlusion of middle cerebral artery (MCAO) model, measuring the volume of cerebral infarct area, the content of oxidation index, inflammatory cytokines, and the expression of CaMMKβ in brain tissue. The in vitro study was explored by oxygen-glucose deprivation/glycogen reoxygenation (OGD/R) model, construction of the CaMMKβ interference sequence, measuring the expression of CaMMKβ in BV2 cells before and after inhibition of CaMMKβ, and the influence of RDPS on Nrf2/HO-1 signal pathway, in order to investigate the possible mechanism. RESULTS: Compared with the model group, the present study showed that RDPS with high-dose and low-dose groups could significantly reduce the volume of cerebral infarction. The content of MDA decreased and the activities of GSH and SOD increased in the two dose groups of RDPS. We confirmed that after RDPS treatment, the levels of IL-6, IL-1 β and TNF-α in brain tissue were lower than those in model group, and the expression of CaMMKβ in brain tissue of rats decreased in the model group, but increased in the groups of RDPS. In the in vitro study, compared with the control group, RDPS could regulate the OGD/R-induced apoptosis of BV2 cells and increase the level of CaMMKβ, Nrf2 and HO-1 induced by OGD/R. To our surprise, these therapeutic effects are no longer present after the inhibition of CaMMKβ protein. The activity of BV2 induced by OGD/R could not be enhanced by RDPS after the inhibition of CaMMKβ protein. CONCLUSIONS: RDPS has the pharmacodynamic effect in IR injury, which reduce the area of cerebral infarction, up-regulate the activity of anti-oxidant kinase, and down-regulate the inflammatory cytokine. Additionally, RDPS could affect the activation of Nrf2/HO-1 signaling pathway by regulating the expression of CaMMKβ. Our observations justify the RDPS could be a new strategy for IR injury therapy, and the mechanism may be related to the improvement of antioxidant enzyme activity and inhibition of inflammatory reaction.
引用
- Shi Z, Deng Z, Peng X, et al. Study on the pharmacodynamic effect of Rhizoma Dioscoreae polysaccharides on cerebral ischemia-reperfusion injury in rats and the possible mechanism. J Ethnopharmacol. 2022. PMID: 35777608. doi:10.1016/j.jep.2022.115517
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。